On Call with the Prairie Doc airs a new live episode at 7 PM on October 8, 2026, covering GLP-1s for diabetes and weight loss plus where the drugs go next.
Recap by typeshit. Post by Facebook on Facebook.
11:54
Ryan Sims of Optimal Health Project gives a follow-up on how things have gone in the months since his 35-pound loss on the experimental drug.
The Tico Times reports Costa Rica's public system is considering offering GLP-1 weight loss drugs to patients. Tap through for where the discussion stands.
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
In the Lilly-funded trial, 31% on the 12 mg dose lost a quarter of their weight, and researchers reported better blood sugar plus lower inflammation markers.
Patients report less back and knee pain as weight drops, but doctors warn fast weight loss can weaken bones, with older users most at risk.
Loading…